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Abstract
Background: Little is known about the interactions of apolipoprotein (Apo) A5 gene polymorphisms and alcohol
consumption on serum lipid profiles. The present study was undertaken to detect the interactions of ApoA5–1131T.C,
c.553G.T and c.457G.A polymorphisms and alcohol consumption on serum lipid levels.
Methodology/Principal Findings: A total of 516 nondrinkers and 514 drinkers were randomly selected from our previous
stratified randomized cluster samples. Genotyping was performed by polymerase chain reaction and restriction fragment
length polymorphism. The levels of serum total cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-
C), ApoA1 and ApoB were higher in drinkers than in nondrinkers (P,0.05–0.001). The genotypic and allelic frequencies of
three loci were not different between the two groups. The interactions between –1131T.C genotypes and alcohol
consumption on ApoB levels (P,0.05) and the ApoA1/ApoB ratio (P,0.01), between c.553G.T genotypes and alcohol
consumption on low-density lipoprotein cholesterol (LDL-C) levels (P,0.05) and the ApoA1/ApoB ratio (P,0.05), and
between c.457G.A genotypes and alcohol consumption on TG levels (P,0.001) were detected by factorial regression
analysis after controlling for potential confounders. Four haplotypes (T-G-G, C-G-G, T-A-G and C-G-T) had frequencies
ranging from 0.06 to 0.87. Three haplotypes (C-G-G, T-A-G, and C-G-T) were significantly associated with serum lipid
parameters. The –1131T.C genotypes were correlated with TG, and c.553G.T and c.457G.A genotypes were associated
with HDL-C levels in nondrinkers (P,0.05 for all). For drinkers, the –1131T.C genotypes were correlated with TC, TG, LDL-C,
ApoB levels and the ApoA1/ApoB ratio (P,0.01 for all); c.553G.T genotypes were correlated with TC, TG, HDL-C and LDL-C
levels (P,0.05–0.01); and c.457G.A genotypes were associated with TG, LDL-C, ApoA1 and ApoB levels (P,0.05–0.01).
Conclusions: The differences in some serum lipid parameters between the drinkers and nondrinkers might partly result
from different interactions of the ApoA5 gene polymorphisms and alcohol consumption.
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Introduction
Dyslipidemia has become a major health problem in many
countries because of its high prevalence and a causal relationship
with serious medical condition such as coronary artery disease
(CAD), hypertension and stroke [1]. It is well known that
dyslipidemia is a complex trait caused by multiple environmental
and genetic factors and their interactions [2–6]. Numerous studies
have evaluated the influence of alcohol consumption on CAD and
plasma lipid concentrations. Low to middle amounts of alcohol
when taken on a regular basis have been shown to protect against
CAD and death [7,8], whereas heavy drinking constitutes a severe
risk condition. A moderate intake of alcohol is associated with
protection against CAD, probably due in part to a dose-dependent
increase in high-density lipoprotein cholesterol (HDL-C) [9–11]. A
decrease in low-density lipoprotein cholesterol (LDL-C) with
increased alcohol intake has also been reported in some studies,
but this effect is less consistent and probably depends on the
combination of one or more unmeasured factors [12]. However,
alcohol in doses .30 g/day in both sexes can augment serum
triglyceride (TG) levels. The alcohol intake of 60 g/day increases
the TG levels by about 0.19 mg/dl per 1 gram of alcohol
consumed [13].
Apolipoprotein (Apo) A5 is a secreted protein present in human
serum and is associated with specific lipoprotein particles. It was
detectable in very low-density lipoprotein (VLDL), HDL, and
chylomicrons. Serum ApoA5 is very low compared with other
apolipoproteins. Human serum ApoA5 concentrations range from
24 to 406 mg/l, with a mean value in normolipidemic persons of
157 mg/l [14], or 179.2674.8 ng/ml in the healthy subjects [15].
ApoA5 is a key regulator of serum TG concentrations. The gene of
ApoA5 was originally identified by experiments looking for new
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which is located on human chromosome 11q23 [16,17]. The
human ApoA5 gene consists of four exons and three introns and
codes for a 369 amino acid protein, ApoA5. It has been reported
that the human ApoA5 transgenic mouse has significantly
decreased TG and the ApoA5 gene knockout mouse significantly
increased plasma TG concentrations as compared with wild-type
mice [17,18]. The adenovirus-mediated overexpression of ApoA5
was associated with markedly decreased (–70%) serum TG levels
caused primarily by the reduced TG content of the VLDL fraction
[19]. These data suggested that ApoA5 expression may be highly
and inversely correlated with TG concentrations. At least 150
single nucleotide polymorphisms (SNPs) have been identified in
the ApoA5 gene (http://www.ncbi.nlm.nih.gov/SNP/). However,
for most of them there are no robust data about their functional
relevance. The minor alleles of several common SNPs in the
human ApoA5 gene locus have been reported to be significantly
associated with increased plasma TG levels [20–44] and the risk of
CAD [45–51] in some studies but not in others [52,53]. We
hypothesize that these conflicting results in diverse populations
might partly result from different gene-environment interactions.
However, little is known about the interactions of ApoA5 gene
polymorphisms and alcohol consumption on serum lipid concen-
trations. Therefore, the aim of the present study was to detect the
interactions of ApoA5 –1131T.C (rs662799), c.553G.T
(rs2075291) and c.457G.A (rs3135507) polymorphisms and
alcohol consumption on serum lipid levels.
Methods
Study subjects
A total of 1030 unrelated subjects who reside in 16 villages in
Napo County, Guangxi Zhuang Autonomous Region, People’s
Republic of China were randomly selected from our previous
stratified randomized cluster samples [2]. The age of the subjects
ranged from 15 to 89 years, with an average age of 43.30617.69
years. There were 516 nondrinkers and 514 drinkers. All of the
subjects were rural agricultural workers. The subjects had no
evidence of diseases related to atherosclerosis, CAD and diabetes.
None of them had been treated with b-adrenergic blocking agents
and lipid-lowering drugs such as statins or fibrates. The present
study was approved by the Ethics Committee of the First Affiliated
Hospital, Guangxi Medical University. Verbal informed consents
and their thumbprints (fingerprints, to express consent) were
obtained from all subjects after they received a full explanation of
the study. Written informed consents were not obtained because
the educational level of the subjects was very low. The procedure
was also approved the Ethics Committee. An incentive of about
ten dollars was provided to each participant in the study.
Epidemiological survey
The survey was carried out using internationally standardized
methods, following a common protocol [54]. Information on
demographics, socioeconomic status, and life style was collected
with standardized questionnaires. Smoking status was categorized
into groups of cigarettes per day: ,20 and $20. Alcohol
consumption was categorized into groups of grams of alcohol
per day: #25 and .25. The physical examination was conducted
by a trained/licensed cardiovascular physician. Blood pressure,
body height, and body weight were measured, and body mass
index (BMI) was calculated as weight (kg) divided by height (m)
squared. Sitting blood pressure was measured three times with use
of a mercury sphygmomanometer after the subjects had a 5 min
rest, and the average of the three measurements was used for
statistical analysis. Systolic blood pressure was determined by the
first Korotkoff sound, and diastolic blood pressure by the fifth
Korotkoff sound.
Biochemical analysis
Venous blood samples (8 ml) were drawn from a forearm vein
of every subject after venous occlusion for a few seconds in a sitting
position, after an overnight fast of 12 h and abstention from
alcohol use for at least 12 h. A part of the sample (3 ml) was
collected into glass tubes and allowed to clot at ambient
temperature, and used to determine serum lipid levels, and
another part of the sample (5 ml) was transferred into tubes with
anticoagulate solution (4.80 g/l citric acid, 14.70 g/l glucose, and
13.20 g/l tri-sodium citrate) and used to extract deoxyribonucleic
acid (DNA). Immediately following clotting serum was separated
by centrifugation for 15 min at 3000 rpm. The levels of serum
total cholesterol (TC), TG, HDL-C, and LDL-C in samples were
determined by enzymatic methods with commercially available
kits, Tcho-1, TG-LH (RANDOX Laboratories Ltd., Ardmore,
Diamond Road, Crumlin Co. Antrim, United Kingdom, BT29
4QY), Cholestest N HDL, and Cholestest LDL (Daiichi Pure
Chemicals Co., Ltd., Tokyo, Japan); respectively. Serum ApoA1
and ApoB levels were assessed by the immunoturbidimetric
Table 1. Comparison of the general characteristics and serum
lipid levels between the nondrinkers and drinkers.
Parameter
Nondrinker
(n=516)
Drinker
(n=514) t (x
2) P
Male/female 186/330 306/208 56.930 0.000
Age (years) 41.26619.53 45.35615.38 –3.733 0.000
Body mass index (kg/m
2) 21.6662.71 21.9562.39 –1.821 0.069
Systolic blood pressure
(mmHg)
120.03616.15 125.60615.63 –5.624 0.000
Diastolic blood pressure
(mmHg)
74.1369.82 77.7969.78 –5.993 0.000
Pulse pressure (mmHg) 45.95611.89 47.83612.01 –2.525 0.012
Cigarette smoking [n (%)]
Nonsmoker 414(80.2) 292(56.8)
,20 cigarettes/day 62(12.0) 106(20.6)
$20 cigarettes/day 40(7.8) 116(22.6) 69.628 0.000
Alcohol consumption
[n (%)]
Nondrinker 516(100.0) –
,25 g/day – 396(77.0)
$25 g/day – 118(23.0)
Total cholesterol (mmol/L) 4.5260.99 4.6560.95 –2.150 0.032
Triglyceride (mmol/L) 0.97(0.57) 1.09(0.61) –2.488 0.013
HDL-C (mmol/L) 1.9860.45 2.1460.49 –5.458 0.000
LDL-C (mmol/L) 2.4060.70 2.4160.70 –0.229 0.819
Apolipoprotein (Apo)
A1 (g/L)
1.4060.16 1.4860.13 –8.805 0.000
ApoB (g/L) 0.8960.22 0.9260.20 –2.290 0.022
ApoA1/ApoB 1.6860.57 1.6960.46 –0.310 0.757
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein
cholesterol. The value of TG was presented as median (interquartile range). The
difference between the two groups was determined by the Wilcoxon-Mann-
Whitney test.
doi:10.1371/journal.pone.0017954.t001
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Ltd.). All determinations were performed with an autoanalyzer
(Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clinical Science
Experiment Center of the First Affiliated Hospital, Guangxi
Medical University.
DNA amplification and genotyping
Total genomic DNA was isolated from peripheral blood
leukocytes using the phenol-chloroform method [5,6]. The
extracted DNA was stored at 4uC until analysis. Genotyping of
the ApoA5 –1131T.C, c.553G.T and c.457G.A was performed
by polymerase chain reaction and restriction fragment length
polymorphism (PCR-RFLP) according to the previous reports
[16,31,50]. For the genotyping of ApoA5 –1131T.C, the sequence
of the forward and backward primers used was 59-GATTGATT-
CAAGATGCATTTAGGAC-39 and 59-CCCCAGGAACTG-
GAGCGAAATT-39 (Sangon, Shanghai, People’s Republic of
China). Each reaction system of a total volume of 25 ml, comprised
0.2 mg of genomic DNA; 0.8 ml of each primer (10 pmol/ml); 4.0 ml
of 106buffersolution; 1.5 ml of MgCl2 (25 mmol/l); 2.0 ml of dNTP
(2.5 mmol/l); and 1.5 U of Taq polymerase (Takara). For the
amplification, initial denaturation at 95uC for 5 min was followed
by 30 cycles of denaturation at 95uC for 30 s, annealing at 61uC for
30 s,andextensionat72uC for45 s, with finalextension at72uC for
7 min. Eight microlitersof the PCRproduct were digested with 3 U
of Tru1I( MseI) at 65uC for 8 h. The digestive products were
separated by electrophoresis on 2% sepharose gel for 60 min. Both
c.553G.T and c.457G.A are naturally occurring restriction
enzyme sites in the exon 4 of ApoA5 gene. To analyze these two
polymorphic markers, exon 4 was amplified using primers 59-
TCGGCGTATGGGTGGAAGAG-39 and 59-GGCAGCAACT-
GAAGCCCTACAC-39 (Sangon, Shanghai, People’s Republic of
China). Each reaction system of a total volume of 25 ml, comprised
0.2 mg of genomic DNA; 0.8 ml of each primer (10 pmol/ml); 4.0 ml
of 106buffersolution; 1.5 ml of MgCl2 (25 mmol/l); 2.0 ml of dNTP
(2.5 mmol/l); and 1.5 U of Taq polymerase (Takara). For the
amplification, initial denaturation at 95uC for 5 min was followed
by 30 cycles of denaturation at 95uC for 30 s, annealing at 61uC for
30 s, andextension at 72uCfor 45 s,withfinalextensionat72uC for
7 min. Each restriction enzyme reaction was performed with 8 mlo f
amplified DNA; 1 mlo f1 0 6buffer solution; and 4 U MspI
(c.553G.T) or 4 U NsbI( FspI, c.457G.A) restriction ezyme in a
total volume of20 ml digested at 37uC overnight. The length ofeach
digested DNA fragment was determined by comparing migration of
a sample with that of standard DNA marker. Stained with ethidium
bromide, the gel was visualized under ultraviolet light and
photographed. Genotypes were scored by an experienced reader
blinded to epidemiological and lipid results.
DNA sequencing
Sixteen samples (each genotype in two) detected by the PCR-
RFLP were also confirmed by direct sequencing. The PCR
product was purified by low melting point gel electrophoresis and
phenol extraction, and then the DNA sequences were analyzed by
using an ABI Prism 3100 (Applied Biosystems) in Shanghai
Sangon Biological Engineering Technology & Services Co., Ltd.,
People’s Republic of China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C, ApoA1,
ApoB levels and the ratio of ApoA1 to ApoB in our Clinical
Science Experiment Center were 3.10–5.17, 0.56–1.70, 0.91–1.81,
1.70–3.20 mmol/L, 1.00–1.76, 0.63–1.14 g/L, and 1.00–2.50;
respectively [2,3]. Hypertension was diagnosed according to the
criteria of 1999 The World Health Organization-International
Society of Hypertension Guidelines for the management of
hypertension [55,56]. The diagnostic criteria of overweight and
obesity were according to the Cooperative Meta-analysis Group of
China Obesity Task Force. Normal weight, overweight and
obesity were defined as a BMI , 24, 24–28, and .28 kg/m
2;
respectively [57].
Statistical analysis
The data were recorded on a pre-designed form and managed
with Excel software. The quantitative variables were presented as
mean 6 standard deviation (serum TG levels were presented as
Figure 1. Genotyping of the ApoA5 gene polymorphisms. (A) ApoA5 c.553G.T. Lane M, 50 bp marker ladder; lanes 1 and 2, the PCR products
of the samples (211 bp); lanes 3 and 4, GG genotype (176 bp and 35 bp); lanes 5 and 6, GT genotype (211 bp, 176 bp and 35 bp). TT genotype was
not be detected in both groups. The 35 bp fragment was invisible in the gel owing to its fast migration speed. (B) ApoA5 –1131T.C. Lanes 1 and 2,
the PCR products of the samples (188 bp); lanes 3 and 4, TT genotype (165 bp and 23 bp); lanes 5 and 6, TC genotype (188 bp, 165 bp and 23 bp);
and Lanes 7 and 8, CC genotype (188 bp). The 23 bp fragment was invisible in the gel owing to its fast migration speed. (C) ApoA5 c.457G.A. Lanes
1 and 2, the PCR products of the samples (211 bp); lanes 3 and 4, GG genotype (211 bp); lanes 5 and 6, GA genotype (211 bp, 133 bp and 78 bp); and
lanes 7 and 8, AA genotype (133 bp and 78 bp).
doi:10.1371/journal.pone.0017954.g001
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characteristics between the two groups was tested by the Student’s
unpaired t test. The frequency of the ApoA5 alleles was
determined by gene counting. A chi-square analysis was used to
evaluate the allelic and genotypic frequencies that were calculated
from the observed genotypic counts, and standard goodness-of-fit
test was used to test the Hardy-Weinberg equilibrium. The
interactions between the ApoA5 genotypes and alcohol consump-
tion on serum lipid parameters were assessed by using a factorial
regression analysis after controlling for potential confounders
including sex, age, BMI, hypertension, and cigarette smoking.
Pair-wise linkage disequilibria (LD) among the three SNPs were
estimated as correlation coefficients (r
2) using the HelixTree
program (GOLDEN Helix, Bozeman, MN, USA). For haplotype
analysis, we estimated haplotype frequencies using the expecta-
tion-maximization algorithm, and determine the association
between haplotypes and lipid phenotypes using trend regression
analysis with the option of composite haplotype estimation
implemented in HelixTree. P values were further adjusted for
multiple tests by a permutation test. The permutation test was
conducted by changing the orders of dependant variable randomly
against the genotypes. Then haplotype trend regression was
conducted based on the same model and a P value was recorded.
In order to evaluate the association of serum lipid parameters with
several environmental factors, alleles (–1131C allele noncarriers =
1, carriers = 2) and genotypes (–1131T.C: TT = 1, TC = 2,
CC = 3; c.553G.T: GG = 1, GT = 2; c.457G.A: GG = 1,
GA/AA = 2; respectively), multiple linear regression analysis with
forward stepwise modeling was also performed in the combined
population, nondrinkers, and drinkers; respectively. The statistical
analyses were performed with the statistical software package
SPSS 13.0 (SPSS Inc., Chicago, Illinois). A P value of less than
0.05 was considered statistically significant.
Results
General characteristics between nondrinkers and
drinkers
Table 1 gives the general characteristics between the nondrink-
ers and drinkers. The ratio of male to female, the mean age, the
levels of systolic blood pressure, diastolic blood pressure and pulse
pressure, and the percentages of subjects who smoked cigarettes
were higher in drinkers than in nondrinkers (P,0.05–0.001).
There was no significant difference in the BMI between the two
groups (P.0.05).
Serum lipid levels between nondrinkers and drinkers
The levels of TC, TG, HDL-C, ApoA1 and ApoB were higher
in drinkers than in nondrinkers (P,0.05–0.001). There was no
significant difference in the levels of LDL-C and the ratio of
ApoA1 to ApoB between the two groups (P.0.05 for each).
Figure 2. A part of the nucleotide sequences of the ApoA5 gene polymorphisms. (A) ApoA5 –1131T.C: (1) TT genotype, (2) TC genotype,
(3) CC genotype; (B) ApoA5 c.553G.T: (4) GG genotype, (5) GT genotype; (C) ApoA5 c.457G.A: (6) GG genotype, (7) GA genotype, (8) AA genotype.
doi:10.1371/journal.pone.0017954.g002
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After the genomic DNA of the samples was amplified by PCR
and imaged by 2% agarose gel electrophoresis for the ApoA5
c.553G.T, the PCR product of 211 bp nucleotide sequences
could be seen in the samples. The GG and GT genotypes were
shown in Figure 1A. The TT genotype was not detected in our
study population. The PCR product of the ApoA5 –1131T.C
was 188 bp nucleotide sequences. The TT, TC and CC genotypes
were shown in Figure 1B. The PCR product of the ApoA5
c.457G.A was 211 bp nucleotide sequences. The GG, GA and
AA genotypes were shown in Figure 1C.
Results of sequencing
The results were shown as TT, TC and CC genotypes of the
–1131T.C, GG and GTgenotypes of the c.553G.T,and GG,GA
and AA genotypes of the c.457G.A by PCR-RFLP, the genotypes
were also confirmed by sequencing (Figure 2); respectively.
Genotypic and allelic frequencies
The genotypic and allelic frequencies of the three SNPs are shown
in Table 2. The genotypic frequencies of each of the three loci were all
in Hardy-Weinberg equilibrium (–1131T.C: x
2=1.524, P=0.217;
c.553G.T: x
2=1.200, P=0.273; c.457G.A: x
2=2.470, P=0.116;
respectively). For three SNPs, –1131T.C was in LD with c.553G.T
(LD coefficient = 0.245, P,0.001) and c.457G.A (LD=0.165,
P,0.001). But c.553G.T variant was not in LD with c.457G.A
(LD=0.048, P=0.126). There was no difference in the genotypic and
allelic frequencies of the three SNPs between the nondrinkers and
drinkers (P.0.05 for all).
Interactions between genotypes and alcohol on lipid
parameters
Table 3 shows the interactions between the ApoA5 genotypes and
alcohol consumption on serum lipid parameters. Interactions
between –1131T.C genotypes and alcohol consumption on serum
ApoB levels (P,0.05) and the ratio of ApoA1 to ApoB (P,0.01) were
detected, the subjects with CC genotype had higher serum ApoB
levels and lower the ratio of ApoAI to ApoB in drinkers than in
nondrinkers. Interactions between c.553G.T genotypes and alcohol
consumption on serum LDL-C levels (P,0.05) and the ratio of
ApoA1 to ApoB (P,0.05) were found, the subjects with GT genotype
had lower serum LDL-C levels and higher the ratio of ApoAI to
Table 2. The genotypic and allelic frequencies of ApoA5 gene polymorphisms between the nondrinkers and drinkers [n (%)].
SNP Group n Genotype [n (%)] Allele [n (%)]
AA AB BB A B
–1131T.C Nondrinker 516 268(51.9) 208(40.3) 40(7.8) 744(72.1) 288(27.9)
(rs662799) Drinker 514 266(51.8) 196(38.1) 52(10.1) 728(70.8) 300(29.2)
x
2 – 1.925 0.411
P – 0.382 0.521
Drinker
,25 g/day 396 206(52.0) 152(38.4) 38(9.6) 564(71.2) 228(28.8)
$25 g/day 118 60(50.8) 44(37.3) 14(11.9) 164(69.5) 72(30.5)
x
2 – 0.515 0.261
P – 0.773 0.609
c.553G.T Nondrinker 516 482(93.4) 34(6.6) – 998(96.7) 34(3.3)
(rs2075291) Drinker 514 480(93.4) 34(6.6) – 994(96.7) 34(3.3)
x
2 – 0.000 0.000
P – 0.988 0.988
Drinker
,25 g/day 396 370(93.4) 26(6.6) – 766(96.7) 26(3.3)
$25 g/day 118 110(93.2) 8(6.8) – 228(96.6) 8(3.4)
x
2 – 0.008 0.007
P – 0.934 0.936
c.457G.A Nondrinker 516 454(88.0) 60(11.6) 2(0.4) 968(93.8) 64(6.2)
(rs3135507) Drinker 514 454(88.3) 52(10.1) 8(1.6) 960(93.4) 68(6.6)
x
2 – 4.168 0.147
P – 0.125 0.701
Drinker
,25 g/day 396 354(89.4) 36(9.1) 6(1.5) 744(93.9) 48(6.1)
$25 g/day 118 100(84.7) 16(13.6) 2(1.7) 216(91.5) 20(8.5)
x
2 – 2.036 1.715
P – 0.361 0.190
Allele A, –1131T, c.553G or c.457G; Allele B, –1131C, c.553T or c.457A; Genotype AA, –1131TT, c.553GG or c.457GG; Genotype AB, –1131TC, c.553GT or c.457GA;
Genotype BB, –1131CC, c.553TT or c.457AA.
doi:10.1371/journal.pone.0017954.t002
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c.457G.A genotypes and alcohol consumption on serum TG levels
(P,0.001) was determined, the subjects with GA/AA genotype had
lower serum TG levels in drinkers than in nondrinkers.
Haplotype analysis
We observed four haplotypes: T-G-G, C-G-G, T-A-G, and C-
G-T with frequencies ranging from 0.06 to 0.87, representing
100% of all haplotypes in the both groups (Table 4). The results
showed that ApoA5 haplotypes were significantly (P,0.05)
associated at the global level with serum TC, TG, HDL-C,
LDL-C, ApoA1, and ApoB levels, even after correction for
multiple testing with permutation test. In particular, carriers of
haplotype C-G-G had significantly higher serum TC, TG, LDL-C
and ApoB levels and lower the ratio of ApoA1 to ApoB than
noncarriers; carriers of haplotype T-A-G had significantly lower
serum TC, HDL-C, LDL-C, ApoA1 and ApoB levels than
noncarriers; and carriers of haplotype C-G-T had higher TG and
lower HDL-C levels than noncarriers (Table 4).
Correlation between genotypes and serum lipid
parameters
Multiple linear regression analysis showed that the –1131T.C
genotypes were correlated with serum TG levels, and c.553G.T
and c.457G.A genotypes were associated with serum HDL-C
levels in nondrinkers (P,0.05 for all). For drinkers, the
–1131T.C genotypes were correlated with serum TC, TG,
LDL-C, ApoB levels and the ratio of ApoA1 to ApoB (P,0.01 for
all); c.553G.T genotypes were correlated with serum TC, TG,
HDL-C and LDL-C levels (P,0.05–0.01); and c.457G.A
genotypes were associated with serum TG, LDL-C, ApoA1 and
ApoB levels (P,0.05–0.01; Table 5). Serum lipid parameters were
also correlated with age, sex, height, weight, BMI, alcohol
consumption, cigarette smoking, and blood pressure in both
nondrinkers and drinkers (Table 6).
Discussion
In the present study, we show that the levels of TC, TG, HDL-
C, ApoA1 and ApoB were lower in nondrinkers than in drinkers.
There was no significant difference in the levels of LDL-C and the
ratio of ApoA1 to ApoB between the two groups. These results are
consistent with those of our previous studies [2,3,5]. Light to
moderate alcohol consumption has been shown to protect against
the development of CAD and mortality [7,8], the dose-response
relation between alcohol consumption and risk of CAD is J- or U-
shaped [4], suggesting that the risk of CAD is greatest when
alcohol consumption is high. The protective effects of regular, light
to moderate alcohol consumption on CAD have been attributed to
Table 3. The interactions between the ApoA5 genotypes and alcohol consumption on serum lipid parameters detected by
factorial regression analysis.
SNP n TC TG HDL-C LDL-C ApoA1 ApoB ApoA1/ApoB
ApoA5 –1131T.C
Nondrinker TT 268 4.4860.92 0.91(0.56) 1.9860.41 2.3760.71 1.4060.13 0.8860.21 1.7160.61
TC 208 4.5561.13 1.00(0.62) 1.9760.50 2.4360.72 1.4060.19 0.9160.22 1.6260.42
CC 40 4.6460.60 0.99(0.57) 2.0060.44 2.4560.60 1.4160.12 0.8760.25 1.8360.87
Drinker TT 266 4.6860.92 0.89(0.53) 2.1560.47 2.3560.72 1.4760.14 0.8960.20 1.7460.50
TC 196 4.8360.82 1.12(0.73) 2.1360.51 2.4260.65 1.4860.13 0.9460.20 1.6660.42
CC 52 5.1760.93 1.38(0.94) 2.1560.55 2.6660.69 1.5060.10 1.0360.20
b 1.5260.30
b
F – 1.143 0.518 0.075 1.006 0.259 4.273 5.059
P – 0.319 0.596 0.928 0.366 0.772 0.014 0.007
ApoA5 c.553G.T
Nondrinker GG 482 4.5161.01 0.93(0.58) 1.9960.46 2.3960.71 1.4060.16 0.8960.22 1.6960.58
GT 34 4.6060.78 1.05(0.62) 1.8360.32 2.5560.67 1.4060.11 0.9860.20 1.4860.32
Drinker GG 480 4.8060.89 1.00(0.60) 2.1660.50 2.4260.70 1.4860.13 0.9260.20 1.6960.44
GT 34 4.6360.90 1.14(1.29) 1.9360.37 2.2360.63
a 1.4560.15 0.9260.27 1.7360.59
a
F – 1.155 1.214 0.476 4.084 0.770 3.600 3.990
P – 0.283 0.271 0.491 0.044 0.380 0.058 0.046
ApoA5 c.457G.A
Nondrinker GG 454 4.5560.97 0.97(0.58) 1.9960.45 2.4160.69 1.4060.15 0.9060.22 1.6760.57
GA/AA 62 4.3161.17 0.99(0.63) 1.8860.46 2.3060.79 1.3760.22 0.8560.24 1.7460.58
Drinker GG 454 4.8160.88 1.01(0.60) 2.1760.50 2.4460.71 1.4960.13 0.9360.21 1.6960.47
GA/AA 60 4.6360.97 0.95(0.49)
b 1.9460.40 2.2260.57 1.4160.14 0.8760.17 1.7060.45
F – 0.102 15.663 1.648 0.554 2.329 0.167 0.288
P – 0.750 0.000 0.200 0.457 0.127 0.683 0.591
SNP, single nucleotide polymorphism; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol;
ApoA1, apolipoprotein A1; ApoB, apolipoprotein B; ApoA1/ApoB, the ratio of apolipoprotein A1 to apolipoprotein B.
The values of F and P are the interactions between the ApoA5 genotypes and alcohol consumption on serum lipid parameters; sex, age, BMI, hypertension, and
cigarette smoking have been controlled for the statistical analyses.
aP,0.05 and
bP,0.01 in comparison with the same genotype of the nondrinker.
doi:10.1371/journal.pone.0017954.t003
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coagulation capacity of platelets, or the suspected role of anti-
oxidant substances contained in alcoholic beverages [59].
According to Rimm et al. [58], a daily dose of 30 g alcohol
results in an average HDL-C level rise of 3.99 mg/dl, and an
ApoA1 level rise of 8.82 mg/dl. The harmful effects of heavy
alcohol consumption on serum lipid profiles may be due to an
increase in plasma TG levels [13,58,60]. Alcohol can cause an
increase of TG lipase activity and a decrease of the HDL removal
from the circulation [12]. In a previous meta-analysis, 30 g of
alcohol daily was associated with a plasma TG increase of
5.69 mg/dl [58]. The alcohol intake of 60 g/day increases the TG
levels by about 0.19 mg/dl per 1 gram of alcohol consumed [13].
The present study shows that there was no significant difference
in the allelic and genotypic frequencies of the three SNPs in
ApoA5 gene between the nondrinkers and drinkers. The
frequency of the –1131C allele in our study populations was
similar to that in Chinese (29.9%) [27,48], Singaporean Chinese
(29.4%) [22], Malays (30.0%) [22], slightly lower than that in
Japanese (34.0%) [18,21], but much greater than that of whites
(8.0%) [16], Hispanic Americans (16.0%) [20,23,26] or Tunisian
(13.0%) [34]. The frequency of the c.553T allele in our study is
extremely low, and is in agreement with that of two previous
studies in Chinese (3.97%) [50] and Chinese Taiwanese (4.2–
7.2%) [31,49]. The c.553T allele has been reported to be absent in
Caucasians [61]. The c.553TT homozygous was not detected in
our study subjects. This is similar to the results in a previous study
[50]. The frequency of c.457A allele was lower in our subjects than
in Chinese Taiwanese (10.27%) [48], but was higher than that
reported for Czechoslovakians in whom the c.457A allele
frequency was 2.04% [62]. These results suggest that there exists
significant racial/ethnic variation of allelic frequencies in ApoA5
gene.
The association of ApoA5 gene polymorphisms and plasma or
serum lipid levels in humans has been evaluated in a large number
of studies [20–44]. However, previous findings are inconsistent
[52,53]. Several separate clinical studies have provided consistent
and strong support for the effect with 24% of whites, 35% of
blacks, and 53% of Hispanics who carry –1131C allele associated
with increased plasma TG levels [16,20,23,63]. But this associa-
tion was not significant in a population-based Spanish control
group [53]. The ApoA5 c.553G.T polymorphism has been found
to correlate strongly with TG levels in Chinese but not in
Caucasians [31,61]. The c.553T allele carriers had significantly
higher plasma TG levels as compared to the wild-type GG
genotype, in both CAD and control groups. In a previous study,
however, Tang et al. [50] did not find any significant associations
between the c.553G.T polymorphism and plasma lipid param-
eters including TC, LDL-C, HDL-C, ApoA1, and ApoB in Han
Chinese recruited from Jiangsu Province, People’s Republic of
China. The association of ApoA5 c.457G.A polymorphism and
plasma lipid levels in humans has not been fully elucidated. In a
Table 4. Association between ApoA5 haplotypes and serum lipid traits in the combined nondrinkers and drinkers.
Lipid Haplotype T-G-G C-G-G T-A-G C-G-T Haplotype global association
– Frequency 0.65 0.26 0.06 0.03 – –
– Frequency (carrier vs
noncarrier)
898 vs 132 454 vs 576 122 vs 908 62 vs 968 PP after
permutation correction
TC Carrier 4.6560.04 4.7560.05 4.5060.09 4.5960.12
(mmol/L) Noncarrier 4.7160.08 4.5860.05 4.7160.04 4.6960.04
P 0.482 0.003 0.017 0.397 ,0.001 0.001
TG Carrier 1.21 (0.06) 1.32 (0.07) 1.58 (0.12) 1.41 (0.16)
(mmol/L) Noncarrier 1.36 (0.11) 1.16 (0.07) 1.19 (0.06) 1.21 (0.06)
P 0.058 ,0.001 0.479 0.006 , 0.001 0.001
HDL-C Carrier 2.1260.02 2.1160.03 1.9960.05 1.9260.06
(mmol/L) Noncarrier 2.0460.04 2.1060.03 2.1360.02 2.1260.02
P 0.065 0.725 0.003 ,0.001 , 0.001 0.001
LDL-C Carrier 2.3760.03 2.4460.04 2.2360.07 2.3360.09
(mmol/L) Noncarrier 2.4460.06 2.3260.04 2.4260.03 2.4060.03
P 0.242 0.004 0.005 0.440 0.002 0.002
ApoA1 Carrier 1.4660.01 1.4660.01 1.4260.01 1.4460.02
(g/L) Noncarrier 1.4460.01 1.4660.01 1.4760.01 1.4760.01
P 0.133 0.769 0.001 0.160 0.001 0.002
ApoB Carrier 0.9060.01 0.9260.01 0.8660.02 0.9460.03
(g/L) Noncarrier 0.9260.02 0.8860.01 0.9260.01 0.9160.01
P 0.401 0.001 0.003 0.259 , 0.001 0.001
ApoA1/ Carrier 1.7260.02 1.6760.03 1.7660.05 1.6660.07
ApoB Noncarrier 1.6960.05 1.7560.03 1.7060.02 1.7160.02
P 0.499 0.005 0.199 0.475 0.129 0.155
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB,
apolipoprotein B; ApoA1/ApoB, the ratio of apolipoprotein A1 to apolipoprotein B. The value was presented as median (interquartile range). The difference among the
genotypes was determined by the Kruskal-Wallis test or the Wilcoxon-Mann-Whitney test.
doi:10.1371/journal.pone.0017954.t004
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polymorphism was not associated with serum TG levels in normal
people. In another recent study, Hubacek et al. [62] showed that
the impact of statin treatment on lipid parameters did not
significantly differ between carriers of the genotypes defined by the
ApoA5 c.457G.A polymorphisms. In the present study, we
showed a significant association between ApoA5 gene polymor-
phisms and some serum lipid parameters. Haplotype analysis with
all three SNPs further supports the strong association between
ApoA5 gene polymorphisms and serum lipid levels in our study
subjects.
The interactions of ApoA5 gene polymorphisms and alcohol
consumption on serum lipid levels are not fully known. In the
present study, we detected an interaction between –1131T.C
genotypes and alcohol consumption on serum ApoB levels and the
ratio of ApoA1 to ApoB, between c.553G.T genotypes and
alcohol consumption on serum LDL-C levels and the ratio of
ApoA1 to ApoB, and between c.457G.A genotypes and alcohol
consumption on serum TG levels. These findings suggest that
some serum lipid parameters in our study subjects were partly
influenced by the interactions of ApoA5 gene polymorphisms and
alcohol consumption. Correlational studies have suggested that the
relation between alcohol consumption and cardiovascular disease
may be influenced by the type of alcohol drunk [64]. A number of
prospective cohort studies have suggested that wine drinkers are at
lower risk of death from all causes of cardiovascular disease than
users of other alcoholic beverages [65–67]. However, the effect of
different types of alcoholic beverages on serum lipid profiles is not
well known. Several epidemiological studies found that regular
consumption of small to moderate amounts of alcoholic beverages,
regardless of the type, resulted in significantly greater levels of
HDL-C [68–70], HDL3-C, and ApoA1 [70] in both males and
females. In two previous studies, however, Ruidavets et al. [71]
found that wine was positively associated with HDL-C. Beer was
positively associated with HDL-C in men and with TG in men and
women. When taking drinking patterns into account, wine
drinkers had higher HDL-C levels than non-wine drinkers. While
Parker et al. [72] showed that both beer and liquor were
Table 5. Correlation between serum lipid parameters and alleles/genotypes in the nondrinkers and drinkers.
Lipid Correlative factor
Unstandardized
coefficient
Standard
error
Standardized
coefficient tP
Nondrinker and drinker
TC ApoA5 c.457G.A genotype –0.183 0.076 –0.070 –2.404 0.016
ApoA5 c.553G.T genotype –0.248 0.114 –0.065 –2.184 0.029
TG ApoA5 –1131 T.C allele 0.297 0.073 0.119 4.067 0.000
ApoA5 c.457G.A genotype –0.853 0.383 –0.248 –2.231 0.026
HDL-C ApoA5 c.553G.T genotype –0.207 0.058 –0.107 –3.569 0.000
LDL-C ApoA5 –1131 T.C genotype 0.079 0.032 0.074 2.476 0.013
ApoA5 c.457G.A genotype –0.137 0.057 –0.071 –2.383 0.017
ApoA1 ApoA5 c.457G.A genotype –0.047 0.012 –0.112 –3.872 0.000
ApoB ApoA5 –1131 T.C genotype 0.034 0.010 0.103 3.534 0.000
ApoA5 c.457G.A genotype –0.040 0.017 –0.068 –2.312 0.021
ApoA1/ApoB ApoA5 –1131 T.C allele –0.087 0.031 –0.084 –2.809 0.005
Nondrinker
TG ApoA5 –1131 T.C allele 0.177 0.081 0.095 2.198 0.028
HDL-C ApoA5 c.553G.T genotype –0.170 0.077 –0.094 –2.214 0.027
ApoA5 c.457G.A genotype –0.111 0.055 –0.084 –2.000 0.046
Drinker
TC ApoA5 –1131 T.C genotype 0.265 0.058 0.198 4.607 0.000
ApoA5 c.553G.T genotype –0.340 0.154 –0.095 –2.200 0.028
TG ApoA5 –1131 T.C genotype 0.320 0.091 0.143 3.502 0.001
ApoA5 c.457G.A genotype –1.414 0.504 –0.363 –2.804 0.005
ApoA5 c.553G.T genotype 0.500 0.244 0.084 2.052 0.041
HDL-C ApoA5 c.553G.T genotype –0.262 0.084 –0.132 –3.112 0.002
LDL-C ApoA5 –1131 T.C genotype 0.140 0.046 0.134 3.067 0.002
ApoA5 c.457G.A genotype –0.202 0.078 –0.111 –2.598 0.010
ApoA5 c.553G.T genotype –0.282 0.121 –0.101 –2.335 0.020
ApoA1 ApoA5 c.457G.A genotype –0.062 0.015 –0.178 –4.202 0.000
ApoB ApoA5 –1131 T.C genotype 0.059 0.013 0.192 4.579 0.000
ApoA5 c.457G.A genotype –0.051 0.022 –0.096 –2.279 0.023
ApoA1/ApoB ApoA5 –1131 T.C genotype –0.126 0.028 –0.185 –4.490 0.000
TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB, apolipoprotein B.
doi:10.1371/journal.pone.0017954.t005
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Lipid Correlative factor
Unstandardized
coefficient Standard error
Standardized
coefficient tP
Nondrinker and drinker
TC Body mass index –0.409 0.073 –1.098 –5.614 0.000
Age 0.014 0.002 0.253 8.586 0.000
Weight 0.211 0.032 1.915 6.623 0.000
Height –0.122 0.020 –1.221 –6.171 0.000
Sex 0.322 0.066 0.168 4.844 0.000
TG Weight 0.410 0.041 2.849 9.958 0.000
Height –0.250 0.026 –1.910 –9.730 0.000
Body mass index –0.846 0.094 –1.738 –8.959 0.000
Sex 0.262 0.088 0.105 2.976 0.003
Alcohol consumption 0.160 0.058 0.088 2.751 0.006
Diastolic blood pressure 0.008 0.004 0.062 2.055 0.040
HDL-C Alcohol consumption 0.139 0.023 0.198 6.027 0.000
Age 0.003 0.001 0.099 3.187 0.001
Sex 0.106 0.031 0.111 3.380 0.001
Weight –0.004 0.002 –0.081 –2.455 0.014
Diastolic blood pressure 0.003 0.002 0.067 2.101 0.036
LDL-C Body mass index 0.052 0.008 0.192 6.460 0.000
Age 0.007 0.001 0.185 6.308 0.000
ApoA1 Alcohol consumption 0.066 0.007 0.302 9.701 0.000
Age 0.001 0.000 0.170 5.811 0.000
Sex 0.046 0.009 0.153 4.980 0.000
ApoB Body mass index 0.019 0.002 0.233 7.968 0.000
Age 0.003 0.000 0.209 7.262 0.000
ApoA1/ApoB Body mass index –0.030 0.006 –0.150 –4.912 0.000
Age –0.003 0.001 –0.106 –3.513 0.000
Nondrinker
TC Age 0.016 0.002 0.320 7.825 0.000
Body mass index 0.078 0.015 0.212 5.160 0.000
Cigarette smoking –0.212 0.068 –0.127 –3.096 0.002
TG Diastolic blood pressure 0.015 0.004 0.156 3.576 0.000
Cigarette smoking –0.179 0.068 –0.115 –2.635 0.009
HDL-C Sex 0.212 0.041 0.226 5.169 0.000
Age 0.004 0.001 0.154 3.637 0.000
Height –0.004 0.002 –0.096 –2.172 0.030
LDL-C Body mass index 0.074 0.011 0.287 7.083 0.000
Age 0.010 0.001 0.276 6.920 0.000
ApoA1 Sex 0.054 0.016 0.166 3.424 0.001
Age 0.002 0.000 0.243 5.932 0.000
Body mass index 0.014 0.004 0.238 3.716 0.000
Cigarette smoking –0.033 0.012 –0.124 –2.607 0.009
ApoB Body mass index 0.023 0.003 0.286 7.080 0.000
Age 0.003 0.000 0.291 7.326 0.000
ApoA1/ApoB Body mass index –0.029 0.009 –0.140 –3.182 0.002
Age –0.004 0.001 –0.144 –3.323 0.001
Drinker
TC Weight 0.026 0.006 0.227 4.483 0.000
Age 0.007 0.003 0.118 2.675 0.008
Sex 0.189 0.087 0.104 2.180 0.030
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group, in men, and in women after covariates were controlled for.
Wine was associated with a significant increase in HDL-C in
women only. Choudhury et al. [9] also showed serum TG levels
were significantly lower in those who drank beer. In our current
study, 90% of the wine drunk by the subjects was corn wine, rice
wine or rum, in which the alcohol content is low. Thus, the
interactions of ApoA5 gene polymorphisms and different kinds of
alcohol consumption on serum lipid levels still need to be
determined.
There are several potential limitations in the present study. First,
the sample size in both groups is a bit small. The individual with
ApoA5c.553TTgenotypeisnotdetected inourpopulation,and the
number of subjects with ApoA5 c.457AA genotype in both groups is
also small. It has been postulated that an adequate analysis of the
polymorphic variants of the ApoA1/ApoC3/ApoA4 gene complex
requires a sample of at least 600 subjects to allow the detection of a
twofold increased risk of disease [73]. Second, the ratio of male to
female, mean age, blood pressure levels, and the percentages of
subjects who smoked cigarettes were higher in drinkers than in
nondrinkers. Although sex, age, BMI, blood pressure, and cigarette
smoking have been adjusted for the statistical analysis, we can not
completely exclude the influence of these factors on serum lipid
levels among different genotypes in both groups. Third, the
interactions of ApoA5 gene polymorphisms and cigarette smoking
on serum lipid levels were not investigated in this study. In several
previous epidemiological studies, we have shown that there was no
significant correlation between cigarette smoking and serum lipid
parameters or the prevalence of hyperlipidemia in our population
[2,3,74]. Fourth, the diet and physical activities were not adjusted
for the statistical analysis. In the present study, the population (Hei
Yi Zhuang) is a special and isolated ethnic subgroup of the Zhuang
minority in China. The population size is 51,655. Because of
isolation from the other ethnic groups, the special customs and
cultures including their clothing, intra-ethnic marriages, diet and
lifestyle are still completely conserved to the present day. The diet in
this population is consistent throughout the year and among
individuals because of the Hei Yi Zhuang’s reliance on a limited
number of locally available food items. Great majority of Hei Yi
Zhuang people live in the mountainous areas. The staple food is
corn gruel or corn tortillas. On ordinary days, they are vegetarians
[2,3,70]. In addition, all of the subjects were rural agricultural
workers. The overall physical activity in the subjects was similar.
Finally, it is well known that serum lipid levels are affected by
multiple environmental and genetic factors, and their interactions.
Although we have detected the interactions of three ApoA5 SNPs
and alcohol consumption on serum lipid levels in this study, there
are still many unmeasured environmental and genetic factors and
their interactions. Thus, the interactions of gene-gene, gene-
environment, and environment-environment on serum lipid levels
remain to be determined.
Conclusion
The present study shows that there was no significant difference
in the genotypic and allelic frequencies of ApoA5 –1131T.C,
c.553G.T and c.457G.A polymorphisms between the non-
drinkers and drinkers. But the interactions of ApoA5 gene
polymorphisms and alcohol consumption on serum lipid levels
are different among the genotypes. The interactions between –
1131T.C genotypes and alcohol consumption on serum ApoB
levels and the ratio of ApoA1 to ApoB, between c.553G.T
genotypes and alcohol consumption on serum LDL-C levels and
the ratio of ApoA1 to ApoB, and between c.457G.A genotypes
and alcohol consumption on serum TG levels were detected in the
present study. The differences in some serum lipid parameters
between the drinkers and nondrinkers might partly result from
different interactions of the ApoA5 gene polymorphisms and
alcohol consumption.
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Lipid Correlative factor
Unstandardized
coefficient Standard error
Standardized
coefficient tP
TG Body mass index –1.340 0.257 –2.149 –5.217 0.000
Weight 0.650 0.110 3.397 5.930 0.000
Height –0.424 0.074 –2.288 –5.706 0.000
HDL-C Body mass index –0.037 0.009 –0.180 –4.181 0.000
Diastolic blood pressure 0.005 0.002 0.104 2.431 0.015
Age 0.003 0.001 0.086 1.996 0.046
ApoA1 Age 0.001 0.000 0.136 2.986 0.003
Height 0.002 0.001 0.103 2.315 0.021
Body mass index –0.007 0.002 –0.120 –2.773 0.006
Diastolic blood pressure 0.002 0.001 0.111 2.553 0.011
ApoB Body mass index 0.012 0.004 0.141 3.361 0.001
ApoA1/ApoB Body mass index 0.264 0.081 1.387 3.252 0.001
Height 0.090 0.023 1.592 3.835 0.000
Weight –0.126 0.035 –2.158 –3.635 0.000
TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; ApoA1, apolipoprotein A1; ApoB, apolipoprotein B.
doi:10.1371/journal.pone.0017954.t006
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